Rapid-onset hyponatremia and delirium following duloxetine treatment for postherpetic neuralgia: Case report and literature review.
Rapid-onset hyponatremia and delirium following duloxetine treatment for postherpetic neuralgia: Case report and literature review.
复制标题
度洛西汀治疗带状疱疹后神经痛后快速发生的低钠血症和谵妄:病例报告和文献综述。
DOI:
10.1097/md.0000000000013178
复制
发表时间:
2018-11
期刊:
影响因子:
1.6
通讯作者:
Xu Y
中科院分区:
文献类型:
--
作者:
Wang D;Lai J;Lu S;Huang M;Hu S;Xu Y
Hyponatremia following duloxetine treatment has been reported in patients with major depressive disorder, fibromyalgia, diabetic neuropathy, or sciatic pain. The manifestations of duloxetine-induced hyponatremia are varying in different individuals. The overall prognosis for this type of hyponatremia is favorable if properly managed. Herein, we reported rapid-onset hyponatremia and delirium in an older patient after 2 doses of duloxetine, which was used to control his postherpetic neuralgia. Laboratory examinations revealed a rapid decline in serum sodium level and indicated the possibility of syndrome of inappropriate antidiuretic hormone (SIADH). Discontinuation of duloxetine, restriction of water intake, and intravenous supplement of normal saline were adopted to manage the hyponatremia. Serum concentration of sodium gradually normalized following aforementioned strategies. Special attention to the electrolyte abnormality is recommended in old patients undergoing duloxetine treatment.